A clinical trial in Europe and Australia will test whether trimetazidine, a heart medication, could improve quality of life ...

Researchers have developed a blood-based test that shows high accuracy for diagnosing ALS as early as up to 10 years before ...

Bulbar ALS has brought speech difficulties for guest writer Nancy Muirhead, but it's also opened her eyes to other forms of ...

Columnist Kristin Neva and her husband, Todd, still find joy in cooking together creatively, especially during their meal prep.

Coya Therapeutics got FDA clearance for a Phase 2 trial in the U.S. to investigate COYA 302 as an ALS treatment.

Marisa Wexler is a senior science writer for ALS News Today with an MS in cellular and molecular pathology. She covers the latest news and information on a variety of amyotrophic lateral sclerosis ...